Tolerance of "on Line" Hemodiafiltration in Chronic Renal Failure Patients
Launched by UNIVERSITY HOSPITAL, MONTPELLIER · Mar 31, 2011
Trial Information
Current as of August 14, 2025
Completed
Keywords
ClinConnect Summary
The aim of this study is to appreciate the tolerance of "on line" HDF treatment versus conventional high flux hemodialysis in term of adverse events occuring during dialysis sessions between day 30 and day 120 of treatment and to evaluate:
* Quality of life evaluated with the KDQOL questionnaire
* Incidence of cardiovascular events
* Influence of the technic on cardiovascular, inflammatory and infectious risk factors
* Mortality
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient who has signed the written consent form
- • Patient aged \> 65 and \< 90 years
- • With creatinine clearance \< 10 mL/min
- • On dialysis for a minimum of 3 months, with 3 times a week hemodialysis sessions
- • Erythropoietin dosage needed to maintain hemoglobin at a constant level (range of hemoglobin: 9-13 g/dL without any variation of more than 2g/dL for less than 3 months)
- • Without any problem of vascular access
- Exclusion Criteria:
- • Patient aged \< 65 and \> 90 years
- • Presence of severe malnutrition (albumin \< 20 g/L)
- • Unstable clinical condition
- • Unipuncture or failed vascular access flow
- • Known problems of coagulation
About University Hospital, Montpellier
The University Hospital of Montpellier is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its commitment to patient-centered care, the hospital collaborates with multidisciplinary teams to explore cutting-edge treatments and therapies across various medical fields. By integrating clinical practice with education and research, the University Hospital of Montpellier aims to enhance health outcomes and contribute to the scientific community's understanding of complex medical conditions. Its robust infrastructure and expertise make it a pivotal player in the landscape of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montpellier, , France
Patients applied
Trial Officials
Didier AGUILERA, Dr
Study Chair
CHG Vichy France
Lynda AZZOUZ, Dr
Study Chair
CH Roanne France
Jean-Marie BATHO, Dr
Study Chair
CH privé Saint Martin Caen France
Francois COMBARNOUS, Dr
Study Chair
Clinique du Tonkin Villeurbanne France
Lotfi CHALABI, Dr
Study Chair
AIDER Montpellier France
Guy DEGREMONT, Dr
Study Chair
CHG Cambrai France
Maxime HOFFMANN, Dr
Study Chair
Clinique de la Louvière Lille France
Gérard DESCHODT, Dr
Study Chair
AIDER Nimes France
Assia DJEMA, Dr
Study Chair
CHG Cholet France
Alain DUBOUST, Dr
Study Chair
Clinique du Vert Galant, Tremblay en France, France
Alexandre DUMOULIN, Dr
Study Chair
CHLM Beziers France
Baya FADEL-BABBA, Dr
Study Chair
AGDUC La Tronche France
Enrique FIGUEROA, Dr
Study Chair
CH Briancon France
Thierry HAAS, Dr
Study Chair
CMCO Evry France
Jean-Michel HARDIN, Dr
Study Chair
CH Soissons France
Daniel HILLION, Dr
Study Chair
CHI Poissy France
Guillaume JEAN, Dr
Study Chair
CRAT Tassin La Demi Lune France
Véronique JOYEUX, Pr
Study Chair
CHU Pontchaillou Rennes France
Kristian KUNZ, Dr
Study Chair
AURAL France
Antoine LACAILLE, Dr
Study Chair
UNHEP Aulnay sous Bois France
Jacques LEBLEU, Dr
Study Chair
Clinique néphrologique Pont Allant Maubeuge France
Vincent LEMAITRE, Dr
Study Chair
CHG Valenciennes France
Mehadji MAAZ, Dr
Study Chair
CH Louis Pasteur Colmar France
Philippe NICOUD, Dr
Study Chair
Clinique Centre Vallée Blanche Chamonix France
Jean-Paul ORTIZ, Dr
Study Chair
Polyclinique Saint Roch Cabestany France
Jacky POTIER, Dr
Study Chair
CH Louis Pasteur Cherbourg France
Olivier PUYOO, Dr
Study Chair
Clinique Néphrologique Occitanie Muret France
Véronique QUERON, Dr
Study Chair
Polyclinique Francheville Perigueux France
Gilles SCHUTZ, Dr
Study Chair
Centre HD Provence Aubagne France
Francois MAURICE, Dr
Study Chair
CHLM Montpellier France
Bruno SEIGNEURIC, Dr
Study Chair
CHU Larrey Toulouse France
Frederic TOLLIS, Dr
Study Chair
CHU Angers France
Carlos VELA, Dr
Study Chair
CH Perpignan France
Francois WAMBERGUE, Dr
Study Chair
Clinique du Bois Lille France
Christian WOLF, Dr
Study Chair
CH Toulon France
Jean-Paul CRISTOL, Pr
Study Chair
CHU Lapeyronie Montpellier France
Bernard CANAUD, Pr
Principal Investigator
CHU Lapeyronie Montpellier France
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials